Exchange Announcement • 12 Jan 2026 20:50
Exchange Announcement • 15 Dec 2025 22:44
Exchange Announcement • 02 Dec 2025 21:12
Exchange Announcement • 13 Nov 2025 17:58
Exchange Announcement • 13 Nov 2025 17:53
𝛼SK or SearchENTITY
Remegen (9995 HK)
Remegen (9995 HK)
275
Analysis
Health Care • China
RemeGen Co., Ltd. operates biotechnology businesses. The Company develops therapeutic antibody drugs such as antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and double antibodies. RemeGen provides solutions autoimmune diseases, tumor diseases, and ophthalmic diseases.
morex